$0.2919
-0.0031-1.05%
Ult. Agg.: Sep 25, 11:09 AM
Vistagen Therapeutics Inc
VTGNNASDAQ
PRO
Vistagen Therapeutics Earnings & Forecasts
Vistagen Therapeutics (VTGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Vistagen Therapeutics Guidance
Recent Earnings Results
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.35 | $-0.30 | $-0.39 | $-0.47 |
| Actual | $-0.30 | $-0.37 | $-0.45 | $-0.54 |
| Surprise | +14.3% | -23.3% | -15.4% | -14.9% |
| Revenue | ||||
| Estimate | $166670 | $320000 | $256520 | $339480 |
| Actual | $1.5M | $465000 | $303000 | $258000 |
| Surprise | +785.6% | +45.3% | +18.1% | -24.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.37 | $-0.36 | $-0.35 | $0.03 |
| Revenue | ||||
| Consensus | $250000 | $250000 | — | — |